Genzyme Begins Phase 3 Pivotal Study of Clolar in Adult Acute Myelogenous Leukemia (08 Sep 2006) phase 3 clinical trial examining the safety and effectiveness of Clolar... to safety, the trial will evaluate the effectiveness of one dose of 40 mg/mē per day.... The trial, designed as a pivotal study for adult AML patients aged 60 and older...
Enzo Biochem Initiates Phase II Trial Of Immunomodulatory Compound For Crohn's Disease (20 Mar 2006) Therapeutics has initiated a Phase II clinical trial to evaluate its immunomodulatory candidate drug EGS21 as a therapeutic for managing Crohn's disease. A Phase I safetytrial of EGS21 was successfully concluded last year. The study is being...
Top
